Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
CA 2376024 A1 · Owner: Astrazeneca Ab · Inventors: Moe, Scott T.; Van Wagenen, Bradford C.; Barmore, Robert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds and pharmaceutical compositions , containing those compounds that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.